Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Disease, Chronic Obstructive
About this trial
This is an interventional treatment trial for Pulmonary Disease, Chronic Obstructive
Eligibility Criteria
Inclusion Criteria:
Outpatients of either sex, 40 years or older, with a diagnosis of COPD (FEV1 65% predicted normal and FEV1/FVC 70%).
Exclusion Criteria:
Patients with significant diseases other than COPD that may either put the patient at risk because of participation in the study or a disease which may influence the results of the study or the patient's ability to participate in the study, with a history of asthma or allergic rhinitis, who regularly use daytime oxygen therapy for more than 1 hour per day and in the investigator's opinion will be unable to abstain from the use of oxygen therapy or using oral corticosteroid me dication at unstable doses (i.e., less than 6 weeks on a stable dose) or at a dose in excess of the equivalent of 10 mg of prednisone per day or 20 mg every other day will be excluded.
Sites / Locations
- 1012.56.01006 Boehringer Ingelheim Investigational Site
- 1012.56.01051 Boehringer Ingelheim Investigational Site
- 1012.56.01071 Boehringer Ingelheim Investigational Site
- 1012.56.01039 Boehringer Ingelheim Investigational Site
- 1012.56.01012 Boehringer Ingelheim Investigational Site
- 1012.56.01029 Boehringer Ingelheim Investigational Site
- 1012.56.01043 Boehringer Ingelheim Investigational Site
- 1012.56.01089 Boehringer Ingelheim Investigational Site
- 1012.56.01021 Boehringer Ingelheim Investigational Site
- 1012.56.01033 Boehringer Ingelheim Investigational Site
- 1012.56.01020 Boehringer Ingelheim Investigational Site
- 1012.56.01045 Boehringer Ingelheim Investigational Site
- 1012.56.01040 Boehringer Ingelheim Investigational Site
- 1012.56.01050 Boehringer Ingelheim Investigational Site
- 1012.56.01018 Boehringer Ingelheim Investigational Site
- 1012.56.01062 Boehringer Ingelheim Investigational Site
- 1012.56.01036 Boehringer Ingelheim Investigational Site
- 1012.56.01025 Boehringer Ingelheim Investigational Site
- 1012.56.01088 Boehringer Ingelheim Investigational Site
- 1012.56.01007 Boehringer Ingelheim Investigational Site
- 1012.56.01058 Boehringer Ingelheim Investigational Site
- 1012.56.01010 Boehringer Ingelheim Investigational Site
- 1012.56.01065 Boehringer Ingelheim Investigational Site
- 1012.56.01024 Boehringer Ingelheim Investigational Site
- 1012.56.01001 Boehringer Ingelheim Investigational Site
- 1012.56.01023 Boehringer Ingelheim Investigational Site
- 1012.56.01052 Boehringer Ingelheim Investigational Site
- 1012.56.01048 Boehringer Ingelheim Investigational Site
- 1012.56.01093 Boehringer Ingelheim Investigational Site
- 1012.56.01077 Boehringer Ingelheim Investigational Site
- 1012.56.01083 Boehringer Ingelheim Investigational Site
- 1012.56.01008 Boehringer Ingelheim Investigational Site
- 1012.56.01019 Boehringer Ingelheim Investigational Site
- 1012.56.01056 Boehringer Ingelheim Investigational Site
- 1012.56.01066 Boehringer Ingelheim Investigational Site
- 1012.56.01090 Boehringer Ingelheim Investigational Site
- 1012.56.01054 Boehringer Ingelheim Investigational Site
- 1012.56.01072 Boehringer Ingelheim Investigational Site
- 1012.56.01070 Boehringer Ingelheim Investigational Site
- 1012.56.01035 Boehringer Ingelheim Investigational Site
- 1012.56.01079 Boehringer Ingelheim Investigational Site
- 1012.56.01044 Boehringer Ingelheim Investigational Site
- 1012.56.01076 Boehringer Ingelheim Investigational Site
- 1012.56.01082 Boehringer Ingelheim Investigational Site
- 1012.56.01049 Boehringer Ingelheim Investigational Site
- 1012.56.01080 Boehringer Ingelheim Investigational Site
- 1012.56.01027 Boehringer Ingelheim Investigational Site
- 1012.56.01028 Boehringer Ingelheim Investigational Site
- 1012.56.01069 Boehringer Ingelheim Investigational Site
- 1012.56.01022 Boehringer Ingelheim Investigational Site
- 1012.56.01015 Boehringer Ingelheim Investigational Site
- 1012.56.01068 Boehringer Ingelheim Investigational Site
- 1012.56.01078 Boehringer Ingelheim Investigational Site
- 1012.56.01017 Boehringer Ingelheim Investigational Site
- 1012.56.01042 Boehringer Ingelheim Investigational Site
- 1012.56.01034 Boehringer Ingelheim Investigational Site
- 1012.56.01031 Boehringer Ingelheim Investigational Site
- 1012.56.01038 Boehringer Ingelheim Investigational Site
- 1012.56.01016 Boehringer Ingelheim Investigational Site
- 1012.56.01067 Boehringer Ingelheim Investigational Site
- 1012.56.01003 Boehringer Ingelheim Investigational Site
- 1012.56.01060 Boehringer Ingelheim Investigational Site
- 1012.56.01004 Boehringer Ingelheim Investigational Site
- 1012.56.01087 Boehringer Ingelheim Investigational Site
- 1012.56.01057 Boehringer Ingelheim Investigational Site
- 1012.56.01026 Boehringer Ingelheim Investigational Site
- 1012.56.01037 Boehringer Ingelheim Investigational Site
- 1012.56.01081 Boehringer Ingelheim Investigational Site
- 1012.56.01085 Boehringer Ingelheim Investigational Site
- 1012.56.01084 Boehringer Ingelheim Investigational Site
- 1012.56.01011 Boehringer Ingelheim Investigational Site
- 1012.56.01073 Boehringer Ingelheim Investigational Site
- 1012.56.01075 Boehringer Ingelheim Investigational Site
- 1012.56.01047 Boehringer Ingelheim Investigational Site
- 1012.56.01014 Boehringer Ingelheim Investigational Site
- 1012.56.01032 Boehringer Ingelheim Investigational Site
- 1012.56.01002 Boehringer Ingelheim Investigational Site
- 1012.56.01053 Boehringer Ingelheim Investigational Site
- 1012.56.01009 Boehringer Ingelheim Investigational Site
- 1012.56.01013 Boehringer Ingelheim Investigational Site
- 1012.56.01059 Boehringer Ingelheim Investigational Site
- 1012.56.01055 Boehringer Ingelheim Investigational Site
- 1012.56.01063 Boehringer Ingelheim Investigational Site
- 1012.56.01005 Boehringer Ingelheim Investigational Site
- 1012.56.01064 Boehringer Ingelheim Investigational Site
- 1012.56.01030 Boehringer Ingelheim Investigational Site
- 1012.56.01074 Boehringer Ingelheim Investigational Site
- 1012.56.54001 Centro Médico de la Dra. De Salvo
- 1012.56.54002 Boehringer Ingelheim Investigational Site
- 1012.56.54003 Policlínica Bancaria
- 1012.56.54004 Hospital Ramos Mejia
- 1012.56.54010 Instituto Lanari
- 1012.56.54011 Boehringer Ingelheim Investigational Site
- 1012.56.54015 Boehringer Ingelheim Investigational Site
- 1012.56.54005 Instituto de Diagnóstico Cardiovascular La Plata
- 1012.56.54012 Boehringer Ingelheim Investigational Site
- 1012.56.54009 Instituto de Investigaciones Clínicas
- 1012.56.54014 Boehringer Ingelheim Investigational Site
- 1012.56.54007 CLINICA PRIVADA de MONTE GRANDE
- 1012.56.54006 CENTRO PRIVADO de MEDICINA RESPIRATORIA
- 1012.56.54008 HOSPITAL ITALIANO de ROSARIO
- 1012.56.54013 Boehringer Ingelheim Investigational Site
- 1012.56.3305A Centre hospitalier Germon & Gauthier
- 1012.56.3303A Clinique de la Louvière
- 1012.56.3301A Hôpital Ambroise Paré
- 1012.56.3304A Centre Médical Erdre Saint Augustin
- 1012.56.3302A Cabinet Médical
- 1012.56.3302B Cabinet Médical
- 1012.56.30001 Boehringer Ingelheim Investigational Site
- 1012.56.30011 Boehringer Ingelheim Investigational Site
- 1012.56.30013 Boehringer Ingelheim Investigational Site
- 1012.56.30009 Boehringer Ingelheim Investigational Site
- 1012.56.30007 Boehringer Ingelheim Investigational Site
- 1012.56.30010 Boehringer Ingelheim Investigational Site
- 1012.56.30002 Boehringer Ingelheim Investigational Site
- 1012.56.30014 Boehringer Ingelheim Investigational Site
- 1012.56.30003 Boehringer Ingelheim Investigational Site
- 1012.56.82009 Boehringer Ingelheim Investigational Site
- 1012.56.82010 Boehringer Ingelheim Investigational Site
- 1012.56.82008 Boehringer Ingelheim Investigational Site
- 1012.56.82001 Boehringer Ingelheim Investigational Site
- 1012.56.82002 Boehringer Ingelheim Investigational Site
- 1012.56.82005 Boehringer Ingelheim Investigational Site
- 1012.56.82006 Boehringer Ingelheim Investigational Site
- 1012.56.82007 Boehringer Ingelheim Investigational Site
- 1012.56.64004 Boehringer Ingelheim Investigational Site
- 1012.56.64001 Boehringer Ingelheim Investigational Site
- 1012.56.64003 Boehringer Ingelheim Investigational Site
- 1012.56.64006 Boehringer Ingelheim Investigational Site
- 1012.56.64005 Boehringer Ingelheim Investigational Site
- 1012.56.48009 Boehringer Ingelheim Investigational Site
- 1012.56.48006 Boehringer Ingelheim Investigational Site
- 1012.56.48007 Boehringer Ingelheim Investigational Site
- 1012.56.48004 Boehringer Ingelheim Investigational Site
- 1012.56.48005 Boehringer Ingelheim Investigational Site
- 1012.56.48002 Boehringer Ingelheim Investigational Site
- 1012.56.48010 Boehringer Ingelheim Investigational Site
- 1012.56.48001 Boehringer Ingelheim Investigational Site
- 1012.56.48011 Boehringer Ingelheim Investigational Site
- 1012.56.48003 Boehringer Ingelheim Investigational Site
- 1012.56.07010 Boehringer Ingelheim Investigational Site
- 1012.56.07001 Boehringer Ingelheim Investigational Site
- 1012.56.07002 Boehringer Ingelheim Investigational Site
- 1012.56.07003 Boehringer Ingelheim Investigational Site
- 1012.56.07005 Boehringer Ingelheim Investigational Site
- 1012.56.07007 Boehringer Ingelheim Investigational Site
- 1012.56.07008 Boehringer Ingelheim Investigational Site
- 1012.56.07009 Boehringer Ingelheim Investigational Site
- 1012.56.27002 Boehringer Ingelheim Investigational Site
- 1012.56.27008 Boehringer Ingelheim Investigational Site
- 1012.56.27001 Boehringer Ingelheim Investigational Site
- 1012.56.27004 Boehringer Ingelheim Investigational Site
- 1012.56.27005 Boehringer Ingelheim Investigational Site
- 1012.56.27009 Boehringer Ingelheim Investigational Site
- 1012.56.27003 Boehringer Ingelheim Investigational Site
- 1012.56.27006 Boehringer Ingelheim Investigational Site
- 1012.56.88604 Chang Gong Memorial Hospital
- 1012.56.88605 Taichung Veterans General Hospital
- 1012.56.88602 Taipei Veterans General Hospital
- 1012.56.88603 National Taiwan University Hospital
- 1012.56.88601 Chang Gung Memorial Hosp-Linkou
- 1012.56.90001 Boehringer Ingelheim Investigational Site
- 1012.56.90005 Boehringer Ingelheim Investigational Site
- 1012.56.90003 Boehringer Ingelheim Investigational Site
- 1012.56.90006 Boehringer Ingelheim Investigational Site
- 1012.56.90002 Boehringer Ingelheim Investigational Site
- 1012.56.38005 Boehringer Ingelheim Investigational Site
- 1012.56.38006 Boehringer Ingelheim Investigational Site
- 1012.56.38001 Boehringer Ingelheim Investigational Site
- 1012.56.38002 Boehringer Ingelheim Investigational Site
- 1012.56.38004 Boehringer Ingelheim Investigational Site
- 1012.56.44009 Boehringer Ingelheim Investigational Site
- 1012.56.44003 Boehringer Ingelheim Investigational Site
- 1012.56.44002 Boehringer Ingelheim Investigational Site
- 1012.56.44006 Colchester General Hospital
- 1012.56.44007 Boehringer Ingelheim Investigational Site
- 1012.56.44001 Medicine Evaluation Unit
- 1012.56.44008 The Staploe Medical Centre
- 1012.56.44005 Morriston Hospital
- 1012.56.44010 Boehringer Ingelheim Investigational Site
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Experimental
COMBIVENT Respimat 20/100 mcg
COMBIVENT CFC-MDI 36/206 mcg
Ipratropium Respimat 20 mcg